Subscribe
The team includes IP shareholders, two of whom will be based in New York
phototrip2403 / Shutterstock.com
17 July 2025NewsCareersSarah Speight

US firm Brownstein nabs five from Crowell ‘at pivotal moment’

Three of the new shareholders have IP and life sciences expertise, bringing a commercial and policy focus to the firm.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Careers
Chicago firm Much Shelist adds partner with ‘entrepreneurial mindset’
11 July 2025   New hire is deeply involved in the litigation space and has co-founded two software businesses.
Careers
Kilpatrick adds ‘seasoned litigator’ as trademark partner
10 July 2025   The new partner brings more than 30 years’ experience, including in counselling pharmaceutical, life sciences, and medical device companies.
Europe
Lord Justice Birss to become chancellor of the High Court
2 July 2025   The prominent senior IP judge is known for his groundbreaking judgments on patents, AI and FRAND, such as Unwired Planet, Thaler's DABUS, and InterDigital.


Editor's picks

IP agencies vital to pharma and biotech grind to a halt
Americas
IP agencies vital to pharma and biotech grind to a halt
2 October 2025

Editor's picks

Americas
IP agencies vital to pharma and biotech grind to a halt
2 October 2025
Americas
Killing the golden goose of US drug innovation (Part II): Drug pricing myths
12 September 2025
Americas
Killing the golden goose of US drug innovation (Part I): Follow the money
10 September 2025
Americas
Smart ringleader: Could Ōura’s market dominance be under threat?
5 September 2025
Americas
Why Masimo’s ‘rare’ move pushes Apple case into uncharted territory
3 September 2025
Europe
Sandoz blocked by UK court from seeking Xarelto profits
2 September 2025

More features

IP agencies vital to pharma and biotech grind to a halt
USPTO trims workforce amid govt shutdown crisis
How impactful is the new USPTO director’s S101 decision?
Global vaccine patents rise, as data reveals shift in Big Pharma strategy
Philips wins unprecedented trade secret sanctions against Chinese defendants
Womble Bond Dickinson partners jump to rival firm
EPO ruling clarifies appeal rights, blocking third-party intervention
Biotech sues AstraZeneca and Cellectis over mRNA patents